Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas

Acta Neuropathologica

Volumn 124, Issue 2, 2012, Pages 247-257

  Godfraind, Catherine ^a   Kaczmarska, Joanna M ^b   Kocak, Mehmet ^b   Dalton, James ^b   Wright, Karen D ^b   Sanford, Robert A ^b   Boop, Fredrick A ^b   Gajjar, Amar ^b   Merchant, Thomas E ^b   Ellison, David W ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Chromosome 1q gain; Ependymoma; Mitotic count; Outcome indicators

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CDKN2A GENE; CELL COUNT; CELL DENSITY; CHILD; CHROMOSOME 1Q; CHROMOSOME 6Q; CHROMOSOME 9; CHROMOSOME 9P; CLINICAL EVALUATION; COHORT ANALYSIS; COPY NUMBER VARIATION; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPENDYMOMA; EXO1 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE LOCUS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LATS1 GENE; MAJOR CLINICAL STUDY; MALE; MITOSIS; OUTCOME ASSESSMENT; OUTCOME VARIABLE; OVERALL SURVIVAL; PATHOLOGY; POSTERIOR CRANIAL FOSSA TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; SCHOOL CHILD; SYMPTOMATOLOGY; TUMOR CELL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 9; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; INFANT; INFRATENTORIAL NEOPLASMS; MALE; PROGNOSIS; RISK FACTORS; SUPRATENTORIAL NEOPLASMS; YOUNG ADULT;

EID: 84865863418     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0981-9     Document Type: Article

References (34)

1. Bennetto L, Foreman N, Harding B, Hayward R, Ironside J, Love S, Ellison D (1998) Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas. Neuropathol Appl Neurobiol 24(6):434-440 (Pubitemid 29002274)
2. Bouffet E, Perilongo G, Canete A, MassiminoM(1998) Intracranial ependymomas in children: a critical reviewof prognostic factors and a plea for cooperation. Med Pediatr Oncol 30(6):319-329
3. Bouffet E, Tabori U, Huang A, Bartels U (2009) Ependymoma: lessons from the past, prospects for the future. Childs Nerv Syst 25 (11):1383-1384 (author reply 1385. DOI:10.1007/s00381-009-0915-6)
4. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison DW (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86(6):929-939 (Pubitemid 34271030)
5. Conklin HM, Li C, Xiong X, Ogg RJ, Merchant TE (2008) Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 26(24):3965-3970. DOI:10.1200/JCO.2007.15.9970
6. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161(6):2133-2141 (Pubitemid 35434859)
7. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 121(3):381-396. DOI:10.1007/s00401-011-0800-8
8. Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, Frappaz D, Massimino M, Grill J, Boyett JM, Grundy RG (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7. DOI:10.1186/1477-5751-10-7
9. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M, Pellissier JF (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93(4):605-613 (Pubitemid 32799294)
10. Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J, Albright AL (1996) Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol Res Pract 192(6):515-522 (Pubitemid 26289857)
11. Godfraind C (2009) Classification and controversies in pathology of ependymomas. Childs Nerv Syst 25(10):1185-1193. DOI: 10.1007/s00381-008-0804-4
12. Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol 8(8):696-705 (Pubitemid 47189085)
13. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158(3):1137-1143 (Pubitemid 32221806)
14. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466(7306):632-636. DOI:10.1038/ nature09173
15. Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schottler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28(19):3182-3190. DOI:10.1200/JCO.2009.27.3359
16. Massimino M, Gandola L, Barra S, Giangaspero F, Casali C, Potepan P, Di Rocco C, Nozza P, Collini P, Viscardi E, Bertin D, Biassoni V, Cama A, Milanaccio C, Modena P, Balter R, Tamburrini G, Peretta P, Mascarin M, Scarzello G, Fidani P, Milano GM, Sardi I, Genitori L, Garre ML (2011) Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy. Int J Radiat Oncol Biol Phys 80(3):807-814. DOI:10.1016/j.ijrobp.2010.02.048
17. McGuire CS, Sainani KL, Fisher PG (2009) Both location and age predict survival in ependymoma: a SEER study. Pediatr Blood Cancer 52(1):65-69. DOI:10.1002/pbc.21806
18. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12(7 Pt 1):2070-2079. DOI:10.1158/1078-0432.CCR-05- 2363
19. Merchant TE (2009) Three-dimensional conformal radiation therapy for ependymoma. Childs Nerv Syst 25(10):1261-1268. DOI:10.1007/s00381-009-0892-9
20. Merchant TE, Fouladi M (2005) Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol 75(3):287-299. DOI:10.1007/s11060-005-6753-9 (Pubitemid 43019484)
21. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10(3):258-266
22. Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B, Roggendorf W (2008) Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182(1):18-26. DOI:10.1016/j.cancergencyto.2007.12.008 (Pubitemid 351323960)
23. Prayson RA (1999) Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 3(1):11-18
24. Preusser M, Heinzl H, Gelpi E, Hoftberger R, Fischer I, Pipp I, Milenkovic I, Wohrer A, Popovici F, Wolfsberger S, Hainfellner JA (2008) Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology 53(1):39-47 (Pubitemid 351861984)
25. Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, Dessen P, Lacroix L, Geoerger B, Job B, Dirven C, Varlet P, Peyre M, Dirks PB, Sainte-Rose C, Vassal G (2009) Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol 27(11):1884-1892. DOI:10.1200/JCO.2007.15.4195
26. Rodriguez D, Cheung MC, Housri N, Quinones-Hinojosa A, Camphausen K, Koniaris LG (2009) Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res 156(2):340-351. DOI:10.1016/j.jss.2009. 04.024
27. Rousseau A, Idbaih A, Ducray F, Criniere E, Fevre-Montange M, Jouvet A, Delattre JY (2010) Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. J Neurooncol 97(3):353-364. DOI:10.1007/s11060-009-0039-6
28. Rousseau E, Palm T, Scaravilli F, Ruchoux MM, Figarella- Branger D, Salmon I, Ellison D, Lacroix C, Chapon F, Mikol J, Vikkula M, Godfraind C (2007) Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma. Mol Cancer 6:47. DOI:10.1186/1476-4598-6-47 (Pubitemid 47307624)
29. Shu HK, Sall WF, Maity A, Tochner ZA, Janss AJ, Belasco JB, Rorke-Adams LB, Phillips PC, Sutton LN, Fisher MJ (2007) Childhood intracranial ependymoma: twenty-year experience from a single institution. Cancer 110(2):432-441. DOI:10.1002/cncr.22782 (Pubitemid 47121905)
30. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8(4):323-335. DOI:10.1016/j.ccr.2005.09.001 (Pubitemid 41443417)
31. Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. Mod Pathol 21(2):165-177. DOI:10.1038/modpathol.3800999 (Pubitemid 351172168)
32. Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, Vaillant B, Goldman S, Packer RJ, Fouladi M, Pollack I, Mikkelsen T, Prados M, Omuro A, Soffietti R, Ledoux A, Wilson C, Long L, Gilbert MR, Aldape K (2012) A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. DOI:10.1007/s00401-012-0941-4
33. Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, Benner A, Hielscher T, Milde T, Remke M, Jones DT, Northcott PA, Garzia L, Bertrand KC, Wittmann A, Yao Y, Roberts SS, Massimi L, Van Meter T, Weiss WA, Gupta N, Grajkowska W, Lach B, Cho YJ, von Deimling A, Kulozik AE, Witt O, Bader GD, Hawkins CE, Tabori U, Guha A, Rutka JT, Lichter P, Korshunov A, Taylor MD, Pfister SM (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20(2):143-157. DOI:10.1016/j.ccr.2011.07.007
34. Zamecnik J, Snuderl M, Eckschlager T, Chanova M, Hladikova M, Tichy M, Kodet R (2003) Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 16(10):980-991. DOI: 10.1097/01.MP.0000087420.34166.B6 (Pubitemid 37280813)